Page 2 - Sanzyme Biologics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanzyme biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanzyme Biologics Today - Breaking & Trending Today

Probiotic strain SNZ 1969 helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Hyderabad (Telangana) [India], November 29 (ANI/PRNewswire): Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects. Irritable bowel syndrome (IBS) is one of the most common disorders of gut-brain interaction, estimated to affect around 11 per cent people globally. The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain. Several factors, such as the increasing fear of antibiotic resistance, the increasing demand of consumers for natural substitutes for drugs, and the emergence of scientific and clinical evidence showing ....

Sanzyme Biologics , Hyderabad Telangana India , Ovember 29 Ani Prnewswire Latest Study Shows Sanzyme Biologics 39s Bacillus Coagulans Snz 1969 Weizmannia , A Natural Spore Forming Probiotic Strain Over Five Decades Of Use And More Than 30 Human Studies Across Age Groups Found To Be Effective In Managing Ibs Symptoms This Study Is Unique As It Covers Both The Diarrhea Constipation With Larger Number Subjects Irritable Bowel Syndrome One Most Common Disorders Gut Brain Interaction , Stimated To Affect Around 11 Per Cent People Globally The Outcome Of This Study Will Be Significant Supplement Manufacturers As It Can Help Design Products Address Consumer Need For Managing Ibs Symptoms Witha Scientifically Studied Probiotic Strain Several Factors , Uch As The Increasing Fear Of Antibiotic Resistance , He Increasing Demand Of Consumers For Natural Substitutes Drugs , Nd The Emergence Of Scientific And Clinical Evidence Showing Efficacy Probiotics , Ave Contributed To Many Health Professionals Considering Probiotics As An Alternative Drug Remedies Ina Randomized , Double Blind , Placebo Controlled Study , Robiotic Potential Of Snz 1969 Has Been Studied In Subjects With Constipation Predominant Irritable Bowel Syndrome Ibsc And Diarrhea Ibsd Significant Reduction Gsrs Ibs Score Was Seen Both The Treatment Group Compared To Placebop Lt 0 0001 Well Tolerated Showed Alleviation Associated Clinical Symptoms Placebo Improved Quality Life Patients This Study Conducted At Apollo Hospitals , Ndia And Published In The International Journal Of Basic Amp Clinical Pharmacology Https Www Ijbcp Com Index Php Article View 5120 Same Strain Has Been Studied Earlier For Gastrointestinal Discomfort , Ntestinal Motility And Intermittent Constipation Among Healthy Subjects Gi Discomfort Study Showed An Improvement In Total Soda Scores , Ncluding Specific Symptoms Such As Burping Belching , Passing Gas , Bad Breath , Nd Sour Taste Compared With Placebo Intestinal Motility Study Concluded That Snz 1969 Reaches The Colon Intact And Ameliorates Gut Microbiota Composition Sanzyme Biologics Was Incorporated In As Uni Sankyo Over Last Five Decades Established Its Strength Probiotics By Developing Scientifically Studied Well Documented Probiotic Strains , Ioneered Their Applications Beyond Human Health Into Aqua , Oultry And Bioremediation Sanzyme Biologics Has Market Presence In Over 40 Countries To Know More , Isit Https Www Sanzymebiologics Com Or Contact Info Ph 91 40 48589999 This Story Is Provided By Prnewswire Ani Will Not Be Responsible In Any Way For The Content Of Article ,